Conditions: Schizophrenia
Keywords: schizophrenia Lurasidone LATUDA
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 388
Healthy volunteers: no

Brief summary:
This is a randomized, double-blind, double-dummy, parallel- controlled, adjustable dose, non-inferiority and multicentre study designed to evaluate the efficacy and safety of lurasidone on schizophrenia for 6 weeks treatment, and to compare with risperidone.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Lurasidone tablets intervention 2: Risperidone tablets
Intervention descriptions: intervention 1: Lurasidone tablets (40or80mg/day) and Risperidone tablets(Placebo) intervention 2: Risperidone tablets(2-6mg/day) and Lurasidone tablets(Placebo)

Protocol document: